Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Otrivine Adult nasal spray
1202020P0BBAAAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 769 |
|
Otrivine Adult 0.1% nasal drops
1202020P0BBADAB
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 287 |
|
Otrivine Child nasal drops
1202020P0BBACAA
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 224 |
|
Otrivine Adult Metered Dose 0.1% nasal spray
1202020P0BBAIAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 130 |
|
Otrivine Congestion Relief 0.1% nasal spray
1202020P0BBAKAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 44 |
|
Otrivine Adult Measured Dose Sinusitis spray
1202020P0BBAHAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 38 |
|
Otrivine Allergy Relief 0.1% nasal spray
1202020P0BBAJAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 17 |
|
Otrivine Adult Menthol nasal spray
1202020P0BBAGAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.